3 Pharmaceutical Stocks to Buy Now

by Portfolio Grader | January 31, 2014 1:15 pm

The grades of three pharmaceutical stocks are better this week, according to the Portfolio Grader[1] database. Every one of these stocks has an “A” (“strong buy”) or “B” overall (“buy”) rating.

Watson Pharmaceuticals (WPI[2]) is making headway this week, with the company’s rating improving to an A (“strong buy”) from a B (“buy”) last week. Watson develops, manufactures, markets, sells and distributes pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of WPI stock[3].

BioDelivery Sciences International, Inc. (BDSI[4]) is bumping up its rating from a C (“hold”) to a B (“buy”) this week. BioDelivery Sciences is a specialty pharmaceutical company that is utilizing licensed and owned proprietary drug delivery technologies to develop and commercialize new formulations of proven therapeutics. Shares of BDSI have increased 32.8% over the past month, better than the 1.3% decrease the Nasdaq has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of BDSI stock[5].

Repros Therapeutics (RPRX[6]) is seeing ratings go up from a C last week to a B this week. Repros Therapeutics is a development stage biopharmaceutical company focusing on the development of oral small molecule drugs for major unmet medical needs. For more information, get Portfolio Grader’s complete analysis of RPRX stock[7].

Louis Navellier’s proprietary Portfolio Grader[8] stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here[9].

Source URL: https://investorplace.com/2014/01/3-pharmaceutical-stocks-to-buy-now-wpi-bdsi-rprx/

---